학술논문
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
Document Type
Article
Author
Source
In Annals of Oncology November 2020 31(11):1518-1525
Subject
Language
ISSN
0923-7534